Browse > Article
http://dx.doi.org/10.4062/biomolther.2014.051

Dioscorea Extract (DA-9801) Modulates Markers of Peripheral Neuropathy in Type 2 Diabetic db/db Mice  

Moon, Eunjung (College of Pharmacy, Gachon University)
Lee, Sung Ok (Graduate School of East-West Medical Science, Kyung Hee University Global Campus)
Kang, Tong Ho (College of Life Sciences, Kyung Hee University Global Campus)
Kim, Hye Ju (Dong-A Pharm Institute)
Choi, Sang Zin (Dong-A Pharm Institute)
Son, Mi-Won (Dong-A Pharm Institute)
Kim, Sun Yeou (College of Pharmacy, Gachon University)
Publication Information
Biomolecules & Therapeutics / v.22, no.5, 2014 , pp. 445-452 More about this Journal
Abstract
The purpose of this study was to investigate the therapeutic effects of DA-9801, an optimized extract of Dioscorea species, on diabetic peripheral neuropathy in a type 2 diabetic animal model. In this study, db/db mice were treated with DA-9801 (30 and 100 mg/kg, daily, p.o.) for 12 weeks. DA-9801 reduced the blood glucose levels and increased the withdrawal latencies in hot plate tests. Moreover, it prevented nerve damage based on increased nerve conduction velocity and ultrastructural changes. Decrease of nerve growth factor (NGF) may have a detrimental effect on diabetic neuropathy. We previously reported NGF regulatory properties of the Dioscorea genus. In this study, DA-9801 induced NGF production in rat primary astrocytes. In addition, it increased NGF levels in the sciatic nerve and the plasma of type 2 diabetic animals. DA-9801 also increased neurite outgrowth and mRNA expression of Tieg1/Klf10, an NGF target gene, in PC12 cells. These results demonstrated the attenuation of diabetic peripheral neuropathy by oral treatment with DA-9801 via NGF regulation. DA-9801 is currently being evaluated in a phase II clinical study.
Keywords
DA-9801; Dioscorea japonica Thunb; Dioscorea nipponica Makino; Diabetic peripheral neuropathy; Nerve growth factor; Type 2 diabetes mellitus;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Singh, U. and Jialal, I. (2008) Alpha-lipoic acid supplementation and diabetes. Nutr. Rev. 66, 646-657.   DOI
2 Spittau, G., Happel, N., Behrendt, M., Chao, T. I., Krieglstein, K. and Spittau, B. (2010) Tieg1/Klf10 is upregulated by NGF and attenuates cell cycle progression in the pheochromocytoma cell line PC12. J. Neurosci. Res. 88, 2017-2025.
3 Srinivasan, K. and Ramarao, P. (2007) Animal models in type 2 diabetes research: an overview. Indian J. Med. Res. 125, 451-472.
4 Toth, C., Schmidt, A. M., Tuor, U. I., Francis, G., Foniok, T., Brussee, V., Kaur, J., Yan, S. F., Martinez, J. A., Barber, P. A., Buchan, A. and Zochodne, D. W. (2006) Diabetes, leukoencephalopathy and rage. Neurobiol. Dis. 23, 445-461.   DOI
5 Traverse, S., Gomez, N., Paterson, H., Marshall, C. and Cohen, P. (1992) Sustained activation of the mitogen-activated protein (MAP) kinase cascade may be required for differentiation of PC12 cells. Comparison of the effects of nerve growth factor and epidermal growth factor. Biochem. J. 288, 351-355.   DOI
6 U.S. Food and Drug Administration (2009) Neurontin packaging insert. http://www.fda.gov/Safety/MedWatch/SafetyInformation/Safety-RelatedDrugLabelingChanges/ucm154552.htm. cited 2012 Aug 24.
7 van Dam, P. S. (2002) Oxidative stress and diabetic neuropathy: pathophysiological mechanisms and treatment perspectives. Diabetes Metab. Res. Rev. 18, 176-184.   DOI   ScienceOn
8 Vincent, A. M., Russell, J. W., Low, P. and Feldman, E. L. (2004) Oxidative stress in the pathogenesis of diabetic neuropathy. Endocr. Rev. 25, 612-628.   DOI   ScienceOn
9 Vinik, A. I., Park, T. S., Stansberry, K. B. and Pittenger, G. L. (2000) Diabetic neuropathies. Diabetologia 43, 957-973.   DOI   ScienceOn
10 Vinik, A. I., Suwanwalaikorn, S., Stansberry, K. B., Holland, M. T., Mc-Nitt, P. M. and Colen, L. E. (1995) Quantitative measurement of cutaneous perception in diabetic neuropathy. Muscle Nerve 18, 574-584.   DOI   ScienceOn
11 Wu, C. L., Lee, C. L. and Pan, T. M. (2009) Red mold dioscorea has a greater antihypertensive effect than traditional red mold rice in spontaneously hypertensive rats. J. Agric. Food Chem. 57, 5035-5041.   DOI
12 Xu, L. and Wang, W. (2002) Chinese materia media: Combinations & applications. Donica Publishing Ltd., Hertfordshire. UK.
13 Zorrilla Hernandez, E., Frati Munari, A., Lozano Castaneda, O., Villalpando Hernandez, S. and Boulton, A. J. (1994) [Diabetic neuropathy. Current concepts on etiopathogenesis, diagnosis, and treatment]. Gac. Med. Mex. 130, 18-25.
14 Calcutt, N. A. (2004) Experimental models of painful diabetic neuropathy. J. Neurol. Sci. 220, 137-139.   DOI
15 Anand, P., Terenghi, G., Warner, G., Kopelman, P., Williams-Chestnut, R. E. and Sinicropi, D. V. (1996) The role of endogenous nerve growth factor in human diabetic neuropathy. Nat. Med. 2, 703-707.   DOI   ScienceOn
16 Apfel, S. C., Arezzo, J. C., Brownlee, M., Federoff, H. and Kessler, J. A. (1994) Nerve growth factor administration protects against experimental diabetic sensory neuropathy. Brain Res. 634, 7-12.   DOI
17 Boden, G. (2001) Pathogenesis of type 2 diabetes. Insulin resistance. Endocrinol. Metab. Clin. North Am. 30, 801-815, v.   DOI
18 Canta, A., Chiorazzi, A., Meregalli, C., Carozzi, V., Oggioni, N., Lauria, G., Lombardi, R., Bianchi, R., Porretta-Serapiglia, C. and Cavaletti, G. (2009) Continuous buprenorphine delivery effect in streptozotocine-induced painful diabetic neuropathy in rats. J. Pain 10, 961-968.   DOI   ScienceOn
19 Choi, S. Z. and Son, M. W. (2011) Novel botanical drug for the treatment of diabetic neuropathy. Arch. Pharm. Res. 34, 865-867.   과학기술학회마을   DOI   ScienceOn
20 Gao, X., Li, B., Jiang, H., Liu, F., Xu, D. and Liu, Z. (2007) Dioscorea opposita reverses dexamethasone induced insulin resistance. Fitoterapia 78, 12-15.   DOI   ScienceOn
21 Gerbitz, K. D., van den Ouweland, J. M., Maassen, J. A. and Jaksch, M. (1995) Mitochondrial diabetes mellitus: a review. Biochim. Biophys. Acta 1271, 253-260.   DOI
22 Hikino, H., Konno, C., Takahashi, M., Murakami, M., Kato, Y., Karikura, M. and Hayashi, T. (1986) Isolation and hypoglycemic activity of dioscorans A, B, C, D, E, and F; glycans of Dioscorea japonica rhizophors. Planta Med. 168-171.
23 Hayes, A. G., Sheehan, M. J. and Tyers, M. B. (1987) Differential sensitivity of models of antinociception in the rat, mouse and guineapig to mu-and kappa-opioid receptor agonists. Br. J. Pharmacol. 91, 823-832.   DOI
24 Hellweg, R. and Hartung, H. D. (1990) Endogenous levels of nerve growth factor (NGF) are altered in experimental diabetes mellitus: a possible role for NGF in the pathogenesis of diabetic neuropathy. J. Neurosci. Res. 26, 258-267.   DOI   ScienceOn
25 Hellweg, R., Raivich, G., Hartung, H. D., Hock, C. and Kreutzberg, G. W. (1994) Axonal transport of endogenous nerve growth factor (NGF) and NGF receptor in experimental diabetic neuropathy. Exp. Neurol. 130, 24-30.   DOI   ScienceOn
26 Hsu, F. L., Lin, Y. H., Lee, M. H., Lin, C. L. and Hou, W. C. (2002) Both dioscorin, the tuber storage protein of yam (Dioscorea alata cv. Tainong No. 1), and its peptic hydrolysates exhibited angiotensin converting enzyme inhibitory activities. J. Agric. Food Chem. 50, 6109-6113.   DOI   ScienceOn
27 Jin, H. Y., Kim, S. H., Yu, H. M., Baek, H. S. and Park, T. S. (2013) Therapeutic potential of dioscorea extract (DA-9801) in comparison with alpha lipoic acid on the peripheral nerves in experimental diabetes. J. Diabetes Res. 2013, 631218.
28 Jung, S., Chung, J. S., Jang, S. M., Guh, J. O., Lee, H. J., Chon, S. U., Kim, K. M., Ha, S. B. and Back, K. (2003) Either soluble or plastidic expression of recombinant protoporphyrinogen oxidase modulates tetrapyrrole biosynthesis and photosynthetic efficiency in transgenic rice. Biosci. Biotechnol. Biochem. 67, 1472-1478.   DOI   ScienceOn
29 Kang, T. H., Moon, E., Hong, B. N., Choi, S. Z., Son, M., Park, J. H. and Kim, S. Y. (2011) Diosgenin from Dioscorea nipponica ameliorates diabetic neuropathy by inducing nerve growth factor. Biol. Pharm. Bull. 34, 1493-1498.   DOI   ScienceOn
30 Kakinoki, B., Sekimoto, S., Yuki, S., Ohgami, T., Sejima, M., Yamagami, K. and Saito, K. (2006) Orally active neurotrophin-enhancing agent protects against dysfunctions of the peripheral nerves in hyperglycemic animals. Diabetes 55, 616-621.   DOI
31 Kim, K. H., Kim, M. A., Moon, E., Kim, S. Y., Choi, S. Z., Son, M. W. and Lee, K. R. (2011a) Furostanol saponins from the rhizomes of Dioscorea japonica and their effects on NGF induction. Bioorg. Med. Chem. Lett. 21, 2075-2078.   DOI   ScienceOn
32 Kim, M. W. (1998) Effect of H2O fraction of Dioscorea japonica Thunb. with selenium on plasma glucose and lipid metabolism in streptozotocin induced diabetic rats. Kor. J. Nutr. 31, 1377-1384.
33 Kim, N., Kim, S. H., Kim, Y. J., Kim, J. K., Nam, M. K., Rhim, H., Yoon, S. K., Choi, S. Z., Son, M., Kim, S. Y. and Kuh, H. J. (2011b) Neurotrophic activity of DA-9801, a mixture extract of Dioscorea japonica Thunb. and Dioscorea nipponica Makino, in vitro. J. Ethnopharmacol. 137, 312-319.   DOI   ScienceOn
34 Maithili, V., Dhanabal, S. P., Mahendran, S. and Vadivelan, R. (2011) Antidiabetic activity of ethanolic extract of tubers of Dioscorea alata in alloxan induced diabetic rats. Indian J. Pharmacol. 43, 455-459.   DOI   ScienceOn
35 Mbiantcha, M., Kamanyi, A., Teponno, R. B., Tapondjou, A. L., Watcho, P. and Nguelefack, T. B. Analgesic and Anti-Inflammatory Properties of Extracts from the Bulbils of Dioscorea bulbifera L. var sativa (Dioscoreaceae) in Mice and Rats. Evid. Based Complement. Alternat. Med. 2011.
36 Oh, P. S. and Lim, K. T. (2008) Plant glycoprotein modulates the expression of interleukin-1beta via inhibition of MAP kinase in HMC-1 cells. Biosci. Biotechnol. Biochem. 72, 2133-2140.   DOI   ScienceOn
37 Nguelefack, T. B., Dutra, R. C., Paszcuk, A. F., Andrade, E. L., Tapondjou, L. A. and Calixto, J. B. (2010) Antinociceptive activities of the methanol extract of the bulbs of Dioscorea bulbifera L. var sativa in mice is dependent of NO-cGMP-ATP-sensitive-K(+) channel activation. J. Ethnopharmacol. 128, 567-574.   DOI
38 Obrosova, I. G. (2003) Update on the pathogenesis of diabetic neuropathy. Curr. Diab. Rep. 3, 439-445.   DOI   ScienceOn
39 Obrosova, I. G. (2009) Diabetic painful and insensate neuropathy: pathogenesis and potential treatments. Neurotherapeutics 6, 638-647.   DOI   ScienceOn
40 Ordonez, G., Fernandez, A., Perez, R. and Sotelo, J. (1994) Low contents of nerve growth factor in serum and submaxillary gland of diabetic mice. A possible etiological element of diabetic neuropathy. J. Neurol. Sci. 121, 163-166.   DOI   ScienceOn
41 Pearlstone, A. C., Oei, M. L. and Wu, T. C. (1992) The predictive value of a single, early human chorionic gonadotropin measurement and the influence of maternal age on pregnancy outcome in an infertile population. Fertil. Steril. 57, 302-304.   DOI
42 Pedicino, D., Liuzzo, G., Trotta, F., Giglio, A. F., Giubilato, S., Martini, F., Zaccardi, F., Scavone, G., Previtero, M., Massaro, G., Cialdella, P., Cardillo, M. T., Pitocco, D., Ghirlanda, G. and Crea, F. (2013) Adaptive immunity, inflammation, and cardiovascular complications in type 1 and type 2 diabetes mellitus. J. Diabetes Res. 2013, 184258.
43 Sima, A. A. and Sugimoto, K. (1999) Experimental diabetic neuropathy: an update. Diabetologia 42, 773-788.   DOI
44 Hiransai, P., Ratanachaiyavong, S., Itharat, A., Graidist, P., Ruengrairatanaroj, P. and Purintrapiban, J. (2010) Dioscorealide B suppresses LPS-induced nitric oxide production and inflammatory cytokine expression in RAW 264.7 macrophages: The inhibition of NF-kappaB and ERK1/2 activation. J. Cell. Biochem. 109, 1057-1063.   DOI   ScienceOn